
In a clinical study, the ingredient Fortetropin was shown to reduce serum myostatin levels while increasing muscle size and mass.

In a clinical study, the ingredient Fortetropin was shown to reduce serum myostatin levels while increasing muscle size and mass.

Probi Select is a patented and clinically documented line of probiotic strains curated to help provide gastrointestinal and immune support.

Lipophytol is a new, highly concentrated phytosterol ingredient with increased water solubility.

Mild cognitive impairment (MCI) is often an early indicator of Alzheimer’s disease. In this study, researchers found that ashwagandha root may improve memory as well as executive function, attention, and information-processing speed in subjects with MCI.

The new formulation offers an alternative way for consumers to get their daily dose of L-lysine in a chewable form, as opposed to the traditional pill forms currently available on the market that must be swallowed.

The new technology can be applied to whey-, milk-, casein-, and plant-based ingredients.

A new canine study shows that Lonza’s Carniking L-carnitine aids dogs’ exercise performance and recovery.

Health Canada approves Rhema Health’s Curcumin BDM30 targeting joint pain and inflammation.

The patent-pending supplement is a combination of Kyowa Hakko’s own Setria glutathoine and L-citrulline that research shows effectively sustains nitric oxide levels.

Daily consumption of phytosterols by millions of adults with severe hypercholesterolemia could save the EU €5.3 billion per year in healthcare costs, according to new Frost & Sullivan analysis.

Researchers found that while curcumin alone has long been considered an effective anti-inflammatory, the addition of turmeric essential oils may improve turmeric’s ability to reduce the severity of colitis symptoms.

Researchers found that most fish oil products on the market in New Zealand do meet regulatory limits for oxidation and label claims about EPA and DHA content.

Today the U.S. Senate voted 57–42 to confirm Scott Gottlieb, MD, as FDA Commissioner.